MR‐proADM as a Prognostic Marker in Patients With ST‐Segment–Elevation Myocardial Infarction—DANAMI‐3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy

BACKGROUND: Midregional proadrenomedullin (MR‐proADM) has demonstrated prognostic potential after myocardial infarction (MI). Yet, the prognostic value of MR‐proADM at admission has not been examined in patients with ST‐segment–elevation MI (STEMI). METHODS AND RESULTS: The aim of this substudy, DAN...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Falkentoft, Alexander C., Rørth, Rasmus, Iversen, Kasper, Høfsten, Dan E., Kelbæk, Henning, Holmvang, Lene, Frydland, Martin, Schoos, Mikkel M., Helqvist, Steffen, Axelsson, Anna, Clemmensen, Peter, Jørgensen, Erik, Saunamäki, Kari, Tilsted, Hans‐Henrik, Pedersen, Frants, Torp‐Pedersen, Christian, Kofoed, Klaus F., Goetze, Jens P., Engstrøm, Thomas, Køber, Lars
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6015359/
https://ncbi.nlm.nih.gov/pubmed/29776961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.008123
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados